Neoplasm Metastasis D009362

Diseases [C] » Neoplasms [C04] » Neoplastic Processes » Neoplasm Metastasis

Description

The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.   MeSH

Hierarchy View

Subtype Terms (6)

Extranodal Extension
 

Lymphatic Metastasis
5 drugs (4 approved, 1 experimental)

Neoplasms, Unknown Primary
14 drugs (12 approved, 2 experimental)

Neoplastic Cells, Circulating
21 drugs (18 approved, 3 experimental)


Approved Indicated Drugs (2)

Phase 3 Indicated Drugs (143)

Phase 2 Indicated Drugs (263)

Phase 1 Indicated Drugs (240)


Organization Involved with Phase 4 Indications (92)

Organization Involved with Phase 3 Indications (229)

AB Science

Aichi Medical University

Aix-University of Marseille

Akron City Hospital

Albert Einstein Israelite Hospital

Allergan

Alpha Biopharma (Jiangsu) Co., Ltd.

Amarin

Ambulancia Klinickej onkologie FNsP Nove Zamky

Angiochem Inc

Anhui College of Traditional Chinese Medicine

Antisoma Research

Arbeitsgruppe Lebermetastasen und Tumoren

Assistance Publique - Hôpitaux de Paris

AstraZeneca

Australasian Gastro-Intestinal Trials Group

Bajcsy-Zsilinszky Hospital

Ballarat Health Services

Bayer

Beijing Municipal Administration of Hospitals

Bellus Health Inc

Betta Pharmaceuticals Co.,Ltd.

Biogen

BioMS Technology Corp.

BioNumerik Pharmaceuticals, Inc.

Biovirtus

Blokhin's Russian Cancer Research Center

Blue Earth Diagnostics

Boehringer Ingelheim

Bristol-Myers Squibb

British Columbia Cancer Agency

Canadian Cancer Trials Group

Canadian Institutes of Health Research (CIHR)

Cancer Research UK

Cantonal Hospital of St. Gallen

Cantonal Hospital Winterthur

Cardiff University

Celgene

Centre Henri Becquerel

Centre Hospitalier Intercommunal Creteil

Centre Hospital Universitaire Hop Huriez

Centre Jean Bernard

Centre Jean Perrin

Centre Leon Berard

Charles University

Chengdu Kanghong Biotech Co.,Ltd.

Chinese Academy of Medical Sciences

Chinese Medical Association

CHU AMBROISE PARE

Chugai

Civi Biopharma, Inc.

Complexo Hospitalario Universitario de A Coruña

Cornell University

Departmental Hosptital of Vendee

Duke University

Dutch Colorectal Cancer Group

Eastern Cooperative Oncology Group

Eicos Sciences, Inc.

Eli Lilly

Epidemiological and Clinical Research Information Network

Erasmus University Rotterdam

European Organisation for Research and Treatment of Cancer

Ev. Krankenhaus Essen-Werden

Faculdade de Medicina do ABC

Federation Francophone de Cancerologie Digestive

Ferrer Internacional S.A.

Flinders University

Fondation Francaise de Cancerologie Digestive

Food and Drug Administration

Free University of Brussels

Fundacao Antonio Prudente

Fundacion Favaloro Para La Docencia e Investigacion Medica

Genentech

Gottfried Wilhelm Leibniz Universität Hannover

Government of Canada

Government of Denmark

Government of Japan

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Groupe Francais De Pneumo-Cancerologie

Guangdong Association of Clinical Trials

Hallym University

Hebrew University

Hetenyi G Korhaz

Hoosier Cancer Research Network

Hospicjum im. Ks. Eugeniusza Dutkiewicza SAC w Gdansku

Hospital de Cancer de Barretos - Fundacao Pio XII

Hospital Sanitas La Moraleja

Hospital Universitario Fundación Alcorcón

Humboldt University

HUYA Bioscience International

ICON

Icon Cancer Center

Immunomedics

Institut de Cancerologie de l'Ouest Paul Papin

Institut Gustave Roussy

Instituto de Oncologia de Rosario

Instituto do Cancer do Estado de São Paulo

Isfahan University

Istituto Giannina Gaslini

Italian Network for Tumor Biotherapy

Japan Clinical Oncology Group

Johns Hopkins University

Johnson and Johnson

J. W. Goethe University

Kantonsspital Graubünden

Keimyung University

King Khaled Eye Specialist Hospital

Klinikum Klagenfurt

Kunming Medical University

L'Hospitalet de Llobregat

Light Sciences Oncology

LintonPharm Co.,Ltd.

Ludwig Maximilians University

MacroGenics

Mario Negri Institute

Masarykuv onkologicky ustav, Klinika komplexni onkologicke pece

MediQuest Therapeutics

Merck

Merck KGaA

Monash University

Moorgreen Hospital, Southampton

NantCell, Inc.

National Cancer Institute, France

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

National Shikoku Cancer Center

Nektar Therapeutics

Nemocnice Horovice

NeuroVita Clinic

New York University

Niepliczny Zakad Opieki Zdrowotnej Zespo Medyczno-Opieku-Czy Alicja Kluczna

Ningbo No. 2 Hospital

Nishinomiya Municipal Central Hospital

Northeastern Ohio Radiology Research and Education Fund

NRG Oncology

NSABP Foundation

Nuhr Medical Center

Oncocenter Onclogie Clinica S.R.L

Oncolab SRL

Oncology department of Nemocnice Benesov

Otsuka

Pan American Collaborative Retina Study Group

Pharmacyclics

Philipps University of Marburg

Polyclinique de L'ormeau

Poradnia Medycyny Paliatywnej Hospicjum Palium

Powiatowy Zespo Zakadow Opieki Zdrowotnej w Bdzinie, Oddzia Opieki Paliatywnej Szpital Czelad

Precision Medicine

Qilu Pharmaceutical Co., Ltd.

Radiation Therapy Oncology Group

Regeneron

Repros Therapeutics

Rocky Mountain Cancer Centers

Royal Marsden Hospital NHS Trust

Russian Foundation of Technological Development

Sanchez Cancer Center

Sanera, s.r.o.

Sanofi

Sanwa Kagaku Kenkyusho Co., Ltd.

Scandinavian Sarcoma Group

Schering-Plough

Semmelweis University

Shandong University

Sichuan University

Sirtex Medical

Sky Ridge Medical Center

Slovak Research Center

Southwest Oncology Group

Spectrum Pharmaceuticals

SRC Bioclinicum

St. Louis University

Stowarzyszenie Przyjacio Chorych Hospicjum

Sue Ryder Home

Organization Involved with Phase 2 Indications (352)

ABX-CRO

Actelion

Actuate Therapeutics Inc.

AEterna Zentaris

Ain Shams University

AIO-Studien-gGmbH

Aju Pharm

Alberta Innovates Health Solutions

Allena Pharmaceuticals

Amal Therapeutics

American Society of Clinical Oncology

A.O. Melegnano - Gorgonzola

Apices Soluciones S.L.

Aposense Ltd.

Apricus Biosciences

Aptose Biosciences Inc.

Aqualis

ARCAGY-GINECO

Array BioPharma

Association of Urogenital Oncology (AUO)

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)

Association pour la Recherche sur le Temps Biologique et la Chronothérapie

Associazione Quovadis

Astellas

Augusta University

AurKa Pharma Inc.

Australia and New Zealand Melanoma Trials Group

Azienda Ospedaliera San Gerardo di Monza

BBB Therapeutics

B. Braun

Beijing InnoCare Pharma Tech Co., Ltd.

Beijing Tricision Biotherapeutics Inc

Biocompatibles International plc

BioMimetix Pharmaceutical, Inc.

Breast Cancer Research Foundation

Brown University

California Pacific Medical Center Research Institute

Cancer Council New South Wales

Cancer Foundation, China

Cancer Research Institute

Cancer Trials Ireland

Carolina Research Professionals, LLC

Case Western Reserve University

Catharina Hospital, Eindhoven, The Netherlands

Catholic University of Sacred Heart, Rome

Cedars-Sinai Medical Center

Celsion

Center Eugene Marquis

Central European Society for Anticancer Drug Research (CESAR)

Centre Georges Francois Leclerc

Centre Hospitalier de la Région d'Annecy

Centre hospitalier Purpan

Centre Paul Strauss

Centre Val d'Aurelle

Cephalon

Chang Gung University

Changhai Hospital

CH Annecy

CHU Besançon

City of Hope National Medical Center

ClinAssess GmbH

Covance

Covis

Curie Institute

Cytogen

Dalian Medical University

DanTrials ApS, Copenhagen, Denmark

Dartmouth University

Daval International Limited

DEKK-TEC, Inc.

Deltanoid Pharmaceuticals

Dent Neurologic Institute

Dent Neuroscience Research Center

Detroit Clinical Research Center

Developmental Therapeutics Consortium

DFB Pharma

Eastern Hepatobiliary Surgery Hospital

ECOG-ACRIN Cancer Research Group

Eisai

Emory University

Endocyte

Enzon

EPS Corporation

Esperas Pharma Inc.

Exelixis

Far Eastern Memorial Hospital

FeRx

First People's Hospital of Hangzhou

Florida International University

Fondation ARC

Fondazione Giovanni Pascale

French Lung Cancer Group

Fujian Medical University

Gabrail Cancer Center

Gachon University

Gem Pharmaceuticals

General Hospital of Chalkida

Geriatric Oncology Consortium

German Breast Group Forschungs GmbH

German Cancer Research Center

Gilead Sciences

Gloucester Pharmaceuticals

Government of Colombia

Government of Mexico

Government of Norway

Government of Taiwan

Gradalis, Inc.

Groupe Oncologie Radiotherapie Tete et Cou

GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU

Grupo Español Multidisciplinar de Melanoma

Grupo Espanol Multidisciplinario del Cancer Digestivo

Grupo Hospital de Madrid

Gruppo Oncologico del Nord-Ovest

Guangzhou Medical University

Guangzhou Trinomab Biotech Co., Ltd.

Guangzhou University

Harvard University

Hellenic Cooperative Oncology Group

Hengrui Therapeutics, Inc.

Herantis Pharma Plc.

Herbert Irving Comprehensive Cancer Center

Hopital Paul Brousse

Hospital General Universitario Gregorio Marañon

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Hospital Universitario de Fuenlabrada

Human Stem Cell Institute, Russia

Hyogo Medical University

Icahn School of Medicine at Mount Sinai

Imclone

Immodulon Therapeutics Ltd

Immunovative Therapies

INC Research

Incyte

Innate Immunotherapeutics

Institut Bergonié

Institut Hospitalier Franco-Britannique

Institut Paoli-Calmettes

Institut Sainte Catherine

Integrated Therapeutics Group

Intergroupe Francophone de Cancerologie Thoracique

Introgen Therapeutics

Ipsen

IQVIA

Isofol Medical AB

Istituto Superiore di Sanità

Italian Trial in Medical Oncology

James Graham Brown Cancer Center

Janssen Pharmaceutica NV

Jazz Pharmaceuticals

Jilin University

Jinan University

Johannes Gutenburg University

Jyoti Clinical and Pathological Laboratory

Kadmon

KAI Pharmaceuticals

Kaohsiung Medical University

Karolinska Institute

Katholieke Universiteit Leuven

Keele University

Kliniken Nordoberpfalz AG Klinikum Weiden Medizinische Kliniken I

Klinikum Oldenburg GmbH

Konkuk University

Korean Urological Oncology Society

Kyushu University

Lille Catholic University

London Regional Cancer Center

Lycera Corp.

Maastricht University

Marche Polytechnic University

Mary Crowley Cancer Center

Mayo Clinic

Medac

Medical College of Wisconsin

MediGene

MedImmune

MedSIR

Melanoma Institute Australia

Memorial Sloan-Kettering Cancer Center

Merck Serono

Methodist Cancer Center, Houston, Texas

MFAR Clinical Research

Mirati Therapeutics Inc.

MS Society

Nanchang University

Nanobiotix

National Cancer Center, Korea

National Cheng Kung University

National Comprehensive Cancer Network

Nationales Centrum fur Tumorerkrankungen

National Institute for Health Research, United Kingdom

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Natural Science Foundation of China

National Taiwan University

Netherlands Cancer Institute

Newark Radiation Oncology

NH TherAguix SAS

Niigata University Medical & Dental Hospital

NKMAX Co., Ltd.

Norwegian Cancer Society

Norwegian University of Science and Technology

NovoCure Ltd.

Ocellaris Pharma, Inc.

ODC Therapy

Ohio State University

OHSU Knight Cancer Institute

Opexa Therapeutics

Osaka City University

Osaka University

OSI Pharmaceuticals

Oslo Metropolitan University

Ospedale di Como

Ospedale di Mantova

Ospedale Fatebenefratelli di Roma

Ospedale S. Giovanni Bellinzona

Ospedaliera Valtellina

Oxford BioMedica

Peter MacCallum Cancer Centre

PETHEMA Foundation

PharmaMar

Philogen S.p.A.

Phoenix Molecular Imaging

PhytoHealth Corporation

Pierre Fabre

Pivotal S.L.

Point Therapeutics

PRACS

Providence Health & Services

PureTech

Radboud University

Rainier Clinical Research Center

Reata Pharmaceuticals, Inc.

Rhode Island Hospital

Robert W. Franz Cancer Center

Rongjie Tao

Russian Academy of Medical Sciences

Rutgers University

RWTH Aachen University

Saint-Joseph University

Sanofi-Synthelabo

SCRI Development Innovations

Seattle Genetics

Second Military Medical University

Shahid Beheshti University of Medical Sciences

Shandong New Time Pharmaceutical Co., LTD

Shandong Provincial Hospital

Shandong Tumor Hospital

Shanghai Armed Police Hospital

Shanghai EpimAb Biotherapeutics Co., Ltd.

Shanghai GeneChem Co., Ltd.

Shanghai University

Shanxi Medical University

Sheffield Hallam University

Sihuan Pharmaceutical Holdings Group Ltd.

Simcere Pharmaceutical Co., Ltd

Soochow University

Southern Medical University

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

State University of New York, Buffalo

Stem Cell Medicine Ltd.

St. Jude Children's Hospital

Taichung Veterans General Hospital

Taipei Veteran General hospital

Technical University of Dresden

Technion University

Temple University

The Adelaide and Meath Hospital

The Christie NHS Foundation Trust

The First People's Hospital of Lianyungang

The Parker Institute

Thomas Jefferson University

Tohoku University

Translational Research Informatics Center, Kobe, Hyogo, Japan

Trans Tasman Radiation Oncology Group

TriHealth

Tsukuba University

Tulane University

UNICANCER

Universidad Complutense de Madrid

Université catholique de Louvain

University of Alabama, Birmingham

University of Arizona

University of Bern

University of Bologna

University of Brescia

University of Buenos Aires

University of Burgundy

University of Calgary

University of California, Davis

University of California, Los Angeles

University of California, San Diego

University of California, San Francisco

University of Cantabria

University of Cincinnati

University of Colorado, Denver

University of Duisburg-Essen

University of Erlangen-Nuremberg

University of Florida

University of Geneva

University of Gothenburg

University of Grenoble

University of Groningen

University of Halle

University of Heidelberg

University of Helsinki

University of Iowa

University of Leicester

University of Leipzig

University of Ljubljana

University of Louisville

University of Magdeburg

University of Maribor

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Milan

University of Minnesota

University of Nebraska

University of New South Wales

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Oslo

University of Oxford

University of Padova

University of Pavia

University of Perugia

University of Pisa

University of Pittsburgh

University of Regensburg

University of Reims

University of Sao Paulo

University of Southern California

University of South Florida

University of Tuebingen

University of Turin

University of Udine

University of Utah

University of Vienna

University of Warwick

University of Western Brittany

University of Wisconsin

Uppsala University

US Biotest

US Oncology

Vanderbilt University

Vastra Gotaland Region

Vedanta Biosciences, Inc.

Vita-Salute University of Milano. Italy

Wayne State University

West Michigan Cancer Center

Wu Jieping Medical Foundation

Yale University

YM Biosciences

Zagazig University

Organization Involved with Phase 1 Indications (130)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.